Latest news
NRx Pharmaceuticals Shares Rise as FDA Completes Initial Review of Ketamine Product - citybizcitybiz · Fri, 07 Aug 2026 18:01:20 GMTNRx Pharma rises on FDA review of ketamine ANDA (NRXP:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 17:08:38 GMTFDA Completes First-Cycle Review of Preservative-Free - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 11:00:00 GMTA vial used in products that shipped 11.9M doses remains in NRx's FDA review - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTStock Market News Today — NYSE, NASDAQ & OTC Headlines - Stock TitanStock Titan · Fri, 07 Aug 2026 01:59:43 GMT